Radiopharm Theranostics reported total assets of $0.43M and total liabilities of $0.27M for the quarter ended Jun 2026. This balance sheet covers 5 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2023 | Jun2024 | Dec2024 | Jun2025 | Jun2026 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & EquivalentsCash & Equiv. | 11.70M | 0.12M | 36.44M | 0.19M | 0.03M |
| Short-term InvestmentsInvestments (Current) | 263.61 | 0.04M | |||
| Cash & Current Investments | 11.70M | 0.12M | 36.48M | 0.19M | 0.03M |
| Receivables - NetNet Receivables | 4.47M | 0.01M | 6.25M | 0.07M | 0.12M |
| Receivables | 4.47M | 0.01M | 6.25M | 0.07M | 0.12M |
| Prepaid Assets | 0.00M | 1.67M | 0.00M | 0.00M | |
| Current Assets | 0.15M | 44.35M | 0.26M | 0.16M | |
| Non-Current Assets | |||||
| Property, Plant & Equipment (Net)PP&E (Net) | 49.19M | 46.63M | |||
| Intangibles | 58.54M | 0.32M | 48.00M | 0.30M | 0.27M |
| Goodwill & Intangibles | 58.54M | 0.32M | 48.00M | 0.30M | 0.27M |
| Other Non-Current Assets | 0.02M | ||||
| Non-Current Assets | 0.32M | 48.10M | 0.30M | 0.27M | |
| Assets | 0.47M | 92.45M | 0.55M | 0.43M | |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payables | 5.12M | 0.07M | 7.33M | 0.06M | 0.07M |
| Notes Payables | 0.18M | 27.30M | 0.18M | 0.13M | |
| Payables | 5.12M | 0.25M | 34.64M | 0.24M | 0.21M |
| Accumulated Expenses | 0.00M | 0.00M | 0.00M | ||
| Other Accumulated Expenses | 0.16M | 0.63M | 0.65M | ||
| Short term Debt | 0.04M | 2.24M | 0.02M | 0.05M | |
| Current Deferred Revenue | 3.16M | 0.01M | 0.01M | ||
| Total Current Liabilities | 0.12M | 13.15M | 0.10M | 0.13M | |
| Non-Current Liabilities | |||||
| Pension | 0.40M | 0.41M | 0.45M | ||
| Minority Interest | -0.01M | -1.20M | -0.01M | -0.02M | |
| Other Non-Current Liabilities | 0.01M | 0.85M | 0.01M | ||
| Total Non-Current Liabilities | 0.18M | 27.30M | 0.18M | 0.13M | |
| Total Liabilities | -45.58M | 0.29M | 40.45M | 0.28M | 0.27M |
| Shareholder's Equity | |||||
| Total Debt | 0.22M | 29.54M | 0.21M | 0.18M | |
| Common Equity | 45.58M | 0.18M | 52.00M | 0.27M | 0.16M |
| Liabilities and Shareholders Equity | 0.47M | 92.45M | 0.55M | 0.43M | |
| Retained Earnings | -0.73M | -127.79M | -0.93M | -1.42M |